Recently, spatial omics has become a powerful tool, enabling researchers to see not only what molecules are present in a ...

A long-read RNA sequencing atlas of 144 paired tumor-normal samples across ten organs shows that gene expression changes ...

A new study in iScience shows that blocking the cannabinoid CB1 receptor with low-dose rimonabant reverses disease-associated ...

TychoBio will test candidate RNA therapies and use PacBio sequencing to measure how each one changes the transcriptome across multiple cell types. Those results will become training data for models ...

With the development of Spatial Transcriptomics, we have become able to see "which genes are expressed where" within a tissue ...

A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose bladder ...

Urine cell-free (cf)RNA analysis could represent a promising biomarker for bladder cancer, according to a study published online Oct. 2 in Nature Medicine. Kevin J. Liu, PhD, from Stanford University ...

Broad RNA profiling could turn a noninvasive urine sample into a tool for characterizing bladder tumors and guiding personalized treatment decisions.

This app note measures cell and sequencing quality in fresh ovarian tumor samples. It then tests cryopreserved samples, where ...

Studies have revealed that the integration of RNA-sequencing and AI-driven precision diagnostics is revolutionising cancer ...

Bulk RNA sequencing (RNA-seq) and single-cell RNA sequencing (scRNA-seq) both quantify gene expression, but they address fundamentally different experimental questions. Bulk RNA-seq captures the ...

TychoBio will test candidate RNA therapies across multiple cell types and use PacBio sequencing to measure changes in the transcriptome following treatment. The resulting data will be used to train ...